首页 > 市场调查报告书 > 製药

再生医学

市场调查报告书

商品编码

1705697

全球诱导性多功能干细胞市场（按细胞来源、应用、最终用户和地区划分）

Global Induced Pluripotent Stem Cells Market, By Cell Source, By Application, By End User, By Geography

出版日期: 2025年03月04日 | 出版商:

Coherent Market Insights | 英文 164 Pages | 商品交期: 2-3个工作天内

价格

简介目录

2025 年全球诱导性多功能干细胞市场规模估计为 15.99 亿美元，预计到 2032 年将达到 33.831 亿美元，2025 年至 2032 年的复合年增长率为 11.3%。

报告范围		报告详细信息
基准年	2024	2025年的市场规模	15.99亿美元
效能数据	2020-2024	预测期	2025-2032
预测期：2025-2032年复合年增长率：	11.30%	2032年价值预测	33.831亿美元

数字。 2025年全球市场占有率诱导性多功能干细胞各地区市占率（%）

诱导性多功能干细胞(iPSC) 是一种可直接从成人细胞产生的多功能细胞。诱导性多功能干细胞的发现彻底改变了再生医学领域，因为它提供了比胚胎干细胞更符合伦理道德的替代方案。诱导性多功能干细胞(iPSC) 是一种经过基因重编程成为类似胚胎干细胞多功能状态的成体细胞。 iPSC 用于再生医学研究，以研究疾病机制、药物发现和毒性筛检。 iPSC 的再生特性为开发以细胞为基础的治疗方法提供了机会。这些细胞透过引入或过度表达关键转录因子从分化的成体细胞重新编程，使其在分化潜力和多功能标记的表达方面回归到类似于胚胎干细胞的状态。这项技术对于开发特异性患者和疾病的干细胞模型以用于药物发现、毒性筛检和再生疗法具有巨大的前景。

市场动态：

全球诱导性多功能干细胞市场受到慢性病发病率上升、器官移植数量增加以及生物製药公司为开发新型干细胞治疗方法而增加的研发 (R&D) 投资的推动。然而，iPS细胞研究和临床应用的高成本以及细胞重编程和干细胞分化的技术挑战正在抑制市场成长。另一方面，干细胞技术的持续进步，例如标准培养方法的建立、无异种重编程方法的开发以及大规模干细胞生产的进展，预计将为市场相关人员提供丰厚的成长机会。

本研究的主要特点

本报告对全球诱导性多功能干细胞市场进行了详细分析，并提供了预测期（2025-2032）的市场规模和年复合成长率(CAGR)，假设 2024 年为基准年。
它还强调了各个领域的潜在收益成长机会，并说明了该市场的一系列有吸引力的投资提案。
它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景和主要企业采用的竞争策略的主要考察。
根据公司亮点、产品系列、关键亮点、业绩和策略等参数，列出了全球诱导性多功能干细胞市场的主要企业。
报告涉及的主要企业包括 Takara Bio、赛默飞世尔科技、FUJIFILM Holdings、Astellas製药、Fate Therapeutics、Ncardia、ViaCyte、Cellular Dynamics International、Lonza、Blueprint Medicines 等。
本报告的见解将使负责人和企业经营团队能够就未来的产品发布、新兴车型、市场扩张和行销策略做出明智的决策。
全球诱导性多功能干细胞市场报告迎合了该行业的各个相关人员，例如投资者、供应商、产品製造商、经销商、新进入者和金融分析师。
相关人员可以透过用于分析全球诱导性多功能干细胞市场的各种策略矩阵来更轻鬆地做出决策。

Report Coverage	Report Details
Base Year:	2024	Market Size in 2025:	USD 1,599.0 Mn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	11.30%	2032 Value Projection:	USD 3,383.1 Mn

Induced pluripotent stem cells (iPSCs) are a type of pluripotent stem cell that can be generated directly from adult cells. The discovery of induced pluripotent stem cells revolutionized the field of regenerative medicine as it provided an ethically superior alternative to embryonic stem cells. Induced pluripotent stem cells (iPSCs) are adult cells that have been genetically reprogrammed to an embryonic stem cell-like pluripotent state. iPSCs are used in regenerative medicine research to study mechanisms of disease and for drug discovery and toxicity screening. Regenerative properties of iPSCs provide opportunities for developing cell-based therapies. These cells are reprogrammed from their original differentiated adult cells through the introduction or overexpression of key transcription factors that enable them to regress to a state that resembles embryonic stem cells in terms of differentiation potential and expression of pluripotency markers. This technology holds tremendous promise for developing patient and disease specific stem cell models for drug discovery, toxicity screening, and regenerative therapies.

Market Dynamics:

Global induced pluripotent stem cells market is driven by rising prevalence of chronic diseases, increasing adoption of organ transplantation and growing research and development (R&D) investments by biopharmaceutical companies for developing novel stem cell-based therapies. However, high costs that are associated with iPSC research and clinical applications, technical challenges in cell reprogramming and stem cell differentiation are restraining wider market growth. Meanwhile, ongoing advancements in stem cell technologies including establishment of standard culture practices, development of xeno-free reprogramming methods and progress in large-scale stem cell production are expected to offer lucrative growth opportunities for market players.

Key features of the study:

This report provides an in-depth analysis of the global induced pluripotent stem cells market, and provides market size (US$ Mn) and compound annual growth rate (CAGR %) for the forecast period (2025-2032), considering 2024 as the base year.
It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players.
It profiles key players in the global induced pluripotent stem cells market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
The key companies covered as a part of this study include Takara Bio Inc., Thermo Fisher Scientific, Fujifilm Holdings Corporation, Astellas Pharma, Fate Therapeutics, Ncardia, ViaCyte, Cellular Dynamics International, Lonza, Blueprint Medicines, and Other Prominent Players.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
Global induced pluripotent stem cells market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global induced pluripotent stem cells market.

Detailed Segmentation:

By Cell Source:
- Skin derived iPSCs
- Blood derived iPSCs
- Urine Derived iPSCs
- Hepatocytes derived iPSCs
- Lung fibroblast derived iPSCs
- Others (Endothelial cells, Glial Cells, Adipose stem cells etc.)
By Application:
- Culture & Maintenance
- Differentiation
- Genetic Manipulation & Engineering
- Characterization & Validation
- Banking & Storage
- Others (Reprogramming kits, Analysis software etc.)
By End User:
- Hospitals
- Diagnostics Centers
- Pharmaceutical & Biotechnology Companies
- Contract Research Organizations
- Others (Academic & Research Institutes etc.)
By Region:
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East
- Africa
Company Profiles
- Takara Bio Inc.
- Thermo Fisher Scientific
- Fujifilm Holdings Corporation
- Astellas Pharma
- Fate Therapeutics
- Ncardia
- ViaCyte
- Cellular Dynamics International
- Lonza
- Blueprint Medicines
- Other Prominent Players

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Global Induced Pluripotent Stem Cells Market Snippet, By Cell Source
- Global Induced Pluripotent Stem Cells Market Snippet, By Application
- Global Induced Pluripotent Stem Cells Market Snippet, By End User
- Global Induced Pluripotent Stem Cells Market Snippet, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Opportunities
Key Highlights
Regulatory Scenario
Recent Trends
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Mergers, Acquisitions, and Collaborations

4. Global Induced Pluripotent Stem Cells Market - Impact of Coronavirus (COVID-19) Pandemic

COVID-19 Epidemiology
Supply Side and Demand Side Analysis
Economic Impact

5. Global Induced Pluripotent Stem Cells Market, By Cell Source, 2020-2032, (US$ Mn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Skin derived iPSCs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
Blood derived iPSCs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
Urine Derived iPSCs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
Hepatocytes derived iPSCs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
Lung fibroblast derived iPSCs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
Others (Endothelial cells, Glial Cells, Adipose stem cells etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)

6. Global Induced Pluripotent Stem Cells Market, By Application, 2020-2032, (US$ Mn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Culture & Maintenance
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
Differentiation
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
Genetic Manipulation & Engineering
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
Characterization & Validation
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
Banking & Storage
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
Others (Reprogramming kits, Analysis software etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)

7. Global Induced Pluripotent Stem Cells Market, By End User, 2020-2032, (US$ Mn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
Diagnostics Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
Pharmaceutical & Biotechnology Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
Contract Research Organizations
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
Others (Academic & Research Institutes etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)

8. Global Induced Pluripotent Stem Cells Market, By Region, 2020-2032, (US$ Mn)

Introduction
- Market Share Analysis, By Region, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, For Region, 2021 - 2032
- Country Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Cell Source, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Mn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Cell Source, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Mn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Cell Source, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Mn)
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Cell Source, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Mn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Cell Source, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Mn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Cell Source, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020-2032,(US$ Mn)
  - South Africa
  - North Africa
  - Central Africa

9. Competitive Landscape

Company Profile
- Takara Bio Inc.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
- Thermo Fisher Scientific
- Fujifilm Holdings Corporation
- Astellas Pharma
- Fate Therapeutics
- Ncardia
- ViaCyte
- Cellular Dynamics International
- Lonza
- Blueprint Medicines
- Other Prominent Players
Analyst Views

10. Section

References
Research Methodology
About us

02-2729-4219

+886-2-2729-4219

License/价格

全球诱导性多功能干细胞市场（按细胞来源、应用、最终用户和地区划分）